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ABSTRACT 
Objective: Effective postoperative pain management promotes better recovery. Continuous epidural (CE) is the standard postoperative analgesia 
for kidney transplantation; however, patients still report pain and unfavorable side effects. This present study compares the effectiveness of 
quadratus lumborum block (QLB) versus CE for managing pain and reducing morphine requirements following kidney transplantation.  
Methods: This randomized-controlled study compared 37 kidney transplant patients: a QLB group (N=19) who received 20 ml 0.375% ropivacaine 
injection bilaterally and a CE group (N=18) who received 0.2% ropivacaine epidurally by infusion at 6 ml/h. Participants were assessed at 2, 6, 12, 
and 24h postoperatively for morphine requirements and with a visual analogue scale (VAS) for pain while resting and moving.  
Results: The VAS scores when resting and moving were similar for both QLB and CE at all-time points (p>0.05 for both treatments). Postoperative 
morphine requirements also did not differ (p>0.05) between the two groups at any time point. Both groups had similar first-time morphine 
requirements (802.63 min for QLB vs 871.39 min for CE, p=0.814). Both groups achieved 100% blockade at the level of T10–L1 and had comparable 
Bromage and Ramsay scores.  
Conclusion: QLB appears to be a viable alternative approach to CE for pain management after kidney transplantation. 
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Kidney transplantation remains the treatment of choice for patients 
with chronic kidney disease (CKD) due to the better quality of life 
provided when compared to other treatment modalities. Indonesia 
has conducted kidney transplantations since 1977, and a total of 270 
patients underwent kidney transplantation between 2011 and 2015 
[1, 2]. 
The kidney transplantation procedure is an open surgery between 
the ribs and pelvis that causes moderate to severe pain 
postoperative pain. Inadequate pain management can disturb the 
inflammatory mediator and immunity systems and eventually 
disrupt the postoperative recovery process. Opioids are widely used 
and provide adequate analgesia, but they have undesirable side 
effects of nausea, vomiting, pruritus and respiratory depression [3–
6]; therefore, continuous epidural (CE) is the current standard of 
care for postoperative analgesia following kidney transplantation. 
However, CE also has side effects, such as paresthesia, hypotension, 
hematomas, impaired lower limb motor function, and prolonged 
urinary catheterization, which can delay recovery and thereby 
increase the risk of graft failure [5, 7, 8]. 
In 2007, Blanco injected the local anesthetic into the interfascial 
surface of anterolateral side quadratus lumborum muscle using 
ultrasound guidance as the lateral quadratus lumborum block (QLB) 
[9]. Unlike CE, QLB does not cause hypotension, has a minimal 
chance of motor block and supporting early mobilization. Some 
studies have shown good visceral analgesia because of the 
paravertebral space and the potential epidural space allow the 
spreading of local anesthetic. A QLB lasts up to 48h with ropivacaine 
(0.375%) as the local anesthetic [10–12]. Our study assessed the 
effectiveness of QLB as a potential alternative for managing pain 
intensity and reducing morphine requirements following kidney 
transplantation in comparison to CE. The primary outcome was a 
24h visual analogue scale (VAS) while resting and moving; the 
secondary outcome was the 24h postoperative morphine 
requirement. The postoperative blockade heights, Bromage and 
Ramsay scores were recorded. 
MATERIALS AND METHODS 
This prospective randomized-controlled study was carried out at a 
university teaching hospital. After registration in ClinicalTrials. gov 
(NCT 03771339) and was approved by the ethical committee, we 
recruited 40 CKD patients scheduled for kidney transplant surgery 
who met the inclusion criteria of age 18 or older. All patients 
provided written consent. Exclusion criteria were patients with body 
mass index above 30 kg/m2, contraindication to CE or QLB 
procedures, and a history of local anesthetic allergy. The study 
protocol, the QLB and CE procedure, VAS 0–100 mm for 
describing the degree of pain, and using the patient-controlled 
analgesia (PCA) morphine pump if their VAS score reached 40 
and above were explained to each patient. The patients were 
randomized into the QLB group (intervention group) or the CE 
group (control group) using a computerized-randomization 
sequence (www.randomizer.org) by independent research 
assistants. The randomization allocation number of each subject was 
written on paper and put in a closed envelope, which was opened by 
the anesthetist appointed to perform epidural or QLB for this study. 
Primary investigators and statisticians were blinded to data 
collection throughout the study. 
All patients underwent standard monitoring, such as electro-
cardiograms, oxygen saturation, non-invasive, and invasive blood 
pressure. Patients in the CE group underwent epidural catheter 
placement under local analgesia before general anesthesia induction. 
An epidural catheter was inserted into intervertebral space between 
thoracic 11–12 at a depth of 4–6 cm within the epidural space using an 
18G Tuohy needle (Perifix®, BBraun, Germany), and the placement 
was confirmed by vacuum catheter aspiration. 
General anesthesia was performed using fentanyl (2 µg/kg), 
propofol (2 mg/kg), and atracurium (0.5 mg/kg) to facilitate the 
intubation. The volume control ventilation was set with a tidal 
volume of 8 ml/kg, PEEP of 5 cmH2O, FiO2 of 0.3–0.5, respiratory 
rate adjustment with ETCO2 target of 35–45 mmHg. The anesthesia 
maintenance was performed using 2.5% sevoflurane with 1.0 L/min 
fresh gas flow, O2 compressed air ratio of 40:60, atracurium 0.5 
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mg/kg/h, with the target of BIS at 40–60, sevoflurane inspired 
fraction of 0.8 and train of four (TOF) ratio  0.25. During surgery, the 
subjects received fentanyl (1 µg/kg) i. v. bolus if the systolic blood 
pressure (SBP) or heart rate increased >20% from the baseline value, 
and the overall administered fentanyl was documented. 
After the surgery, the CE group was given an epidural regimen of 
ropivacaine (0.2%) and epinephrine (1:200,000) in a total volume of 3 
ml as a test dose. Upon confirmation of a negative test dose, 
ropivacaine 0.2% was maintained at 6 ml/h. In the QLB group, the 
patients underwent ultrasonography-guided (C5-1E, DC-70, Mindray, 
Shenzhen China) bilateral injection of ropivacaine (0.375%) with a 
total volume of 20 ml on each side using a 21G 100-mm peripheral 
block needle (Stimuplex®, BBraun, Germany). The block was 
performed by anesthetist consultants using anterior QLB approach. 
Neostigmine (0.04–0.07 µg/kg) was given to reverse the residual 
neuromuscular block, and the patient was extubated upon reaching 
a TOF of 0.9–1.0. The PCA morphine was administered i. v. through a 
programmed pump (Perfusor® Space PCA, BBraun, Germany) with 1 
mg bolus, 10 min lock time, and maximum dosage of 6 mg/h without 
basal opioid infusion. Participants were re-educated regarding the 
PCA usage and VAS reporting and were assessed at 2, 6, 12, and 24h 
postoperatively for pain with the VAS while resting and moving and 
for their morphine requirements. 
We hypothesized that achieving the difference of 50% in 24 h 
morphine consumption or 25 points of VAS difference between the 
two groups was clinically relevant for sample size determination of 
18 subjects per group. We applied the Statistical Package for Social 
Sciences version 20.0 (IBM Corp., Armonk, New York) in analyzing 
the data. A two-sample t-test for normally distributed data and the 
Mann-Whitney test for data without a normal distribution were 
applied to analyze numerical variables differentiation. Categorical 
variables were assessed using the chi-square test. Numerical data 
with a normal distribution were shown as means (standard 
deviation), and data without a normal distribution were presented 
as medians (minimum-maximum), while categorical variables were 
presented as absolute counts (percentages). Differences were 
considered statistically significant if the p-value was less than 0.05. 
RESULTS 
This study enrolled 40 subjects between November 2018 and August 
2019. The subjects were randomly assigned to the two groups and 
underwent their allocated intervention. Three subjects were 
excluded for failure to comply with the PCA utilization rules that had 
been explained. The remaining 37 subjects were analyzed (fig. 1). 
The QLB and CE groups showed similar demographic baseline and 
perioperative characteristics (table 1). 
 
 
Fig. 1: CONSORT flow diagram 
CE: continuous epidural; QLB: quadratus lumborum block. 
 
Table 1: Baseline subject characteristics and intraoperative data 
Characteristic CE group (n=18) QLB group (n=19) p-value* 
Male 14(77.8) 12(63.2) 0.540 
Age (years) 42.00±11.282 43.47±11.27 0.694 
Weight (kg) 65.42±9.43 67.88±13.09 0.515 
Height (cm) 166.44±9.31 167.89±8.18 0.619 
Body mass index (kg/m2) 23.54±2.88 23.84±2.75 0.749 
Duration of surgery (h) 5.20±1.21 5.21±0.648 0.987 
Duration of anesthesia (h) 6.70±1.12 6.61±0.63 0.762 
Intraoperative fentanyl (mcg) 279.17±73.39 248.68±103.57 0.024 
Categorical data are presented as n (%), numerical data are presented as mean±standard deviation, *two-sample t-test, p<0.05 considered 
significant, CE: continuous epidural; QLB: quadratus lumborum block 
 
Pain scores at rest and during movement during 24h after anesthesia 
recovery did not differ significantly between the QLB and groups. The 
lowest pain scores in both groups at rest and in the movement were 
immediately after surgery and after 12h of anesthesia recovery (table 2). 
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Table 2: VAS comparisons between groups 
 CE group (n=18) QLB group (n=19) p-value 
VAS at rest during post-anesthesia recovery (mm) 
immediate 0 (0–20) 0 (0–45) 0.228* 
2h 10 (0–33) 15 (0–70) 0.108* 
6h 10 (0–20) 10 (0–30) 0.224* 
12h 10 (0–20) 10 (0–30) 0.056* 
24h 10 (0–20) 10 (0–35) 0.179* 
VAS while moving during post-anesthesia recovery (mm) 
immediate 10 (0–40) 10 (0–45) 0.813* 
2h 30 (0–50) 30 (10–85) 0.865* 
6h 27.5 (0–50) 25 (10–50) 0.947 
12h 20 (0–50) 30 (10–50) 0.063 
24h 20 (10–80) 20 (0–50) 0.408* 
Numerical data presented as median (minimum-maximum), *Mann-Whitney test, p<0.05 considered significant, two-sample t-test, p<0.05 
considered significant, CE: continuous epidural; QLB: quadratus lumborum block 
 
Table 3 shows comparable cumulative morphine requirements for 
both groups at each time point of measurements. The time to first 
morphine initiation using PCA did not differ significantly between the 
QLB and CE (802.63 vs 871.39 min, p=0.814). Overall, 8 subjects in the 
QLB group and 7 subjects in the epidural group did not need additional 
morphine during the 24h after anesthesia recovery. 
  
Table 3: PCA (morphine) requirements 
 CE group (n=18) QLB group (n=19) p-value* 
PCA Morphine Requirements (mg) 
2h 2 (0–2) 2 (0–2) 0.380 
6h 2 (0–2) 2 (0–2) 0.425 
12h 2 (0–2) 2 (0–3) 0.664 
24h 0 (0–5) 0 (0–4) 0.854 
Total cumulative morphine 1 (0–12) 2 (0–9) 0.789 
First postoperative morphine required (min) 
First PCA attempt 920 (30–1440) 420 (60–1440) 0.814 
Numerical data presented as median (minimum-maximum)., *Mann-Whitney test, p<0.05 considered significant, CE: continuous epidural; QLB: 
quadratus lumborum block; PCA: patient-controlled analgesia 
 
The Bromage score (table 4) showed no motor block between 
groups, except for one subject in the epidural group who reported 
paresthesia and a partial motor block, which resolved without any 
intervention within a 12h observation period. All subjects were 
cooperative, oriented and tranquil at all assessed time points 
according to the Ramsay sedation scale (table 5). 
 
Table 4: Bromage score comparison between groups 
Bromage score 1 2 p-Value* 
CE QLB CE QLB  
at RR 18(100) 19(100) 0(0) 0(0) 1.000 
2h 17(94.4) 25(100) 1(5.6) 0(0) 0.775 
6h 17(94.4) 25(100) 1(5.6) 0(0) 0.775 
12h 18(100) 19(100) 0(0) 0(0) 1.000 
24h 18(100) 19(100) 0(0) 0(0) 1.000 
Data presented in n (%). CE: continuous epidural; QLB: quadratus lumborum block; RR: recovery room; 1: nil block; 2: partial block, *Mann-Whitney 
test, p<0.05 is significant. 
 
Table 5: Ramsay score comparison between groups 
Ramsay score 2 p-Value* 
CE QLB 
at RR 18(100) 19(100) 1.000 
2h 18(100) 19(100) 1.000 
6h 18(100) 19(100) 1.000 
12h 18(100) 19(100) 1.000 
24h 18(100) 19(100) 1.000 
Data presented in n (%). CE: continuous epidural; QLB: quadratus lumborum block; RR: recovery room; 2: cooperative, *Mann-Whitney test, p<0.05 
is significant. 
 
Fig. 2 shows the variable degree of sensory block spread in both groups. 
The majority of the patients in the QLB group had a loss of cold and 
pinprick sensations from T10 to L1, compared with the majority of 
patients in the CE group, who had a loss of cold and pinprick sensations 
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from T9 to L1. None of the patients in the QLB group showed sensory 
blockade at T7 or L2 levels. Complications such as local anesthetic 
systemic toxicity, hematoma, local infection, and blocked or dislodged 
epidural catheters were not found during study observation. 
  
 
Fig. 2: Postoperative sensory block coverage comparison 
 
The maximum and minimum dosages of vasoactive drugs 
(norepinephrine and dobutamine) were recorded for 24h 
postoperatively (table 6). We found 2 subjects in the QLB group and 
3 subjects in the CE group did not require vasoactive drugs 
postoperatively. The norepinephrine and dobutamine dosages 
between the two groups were not statistically significantly different. 
The total urine production for the first 24h was 7,590±518 ml in the 
QLB group and 8,399±1,608 ml in the CE group (p=0.679), with the 
urine output of 4.76±0.39 ml/kg/h in the QLB group and 5.47±1.07 
ml/kg/h in the CE group (p=0.581). 
 
Table 6: Vasoactive drugs requirements 
 CE group (n=18) QLB group (n=19) p-value* 
Norepinephrine (µg/kg/min) 
Minimum  0.003 (0–0.10) 0 (0–0.20) 0.816 
Maximum 0.050 (0–0.5) 0.09 (0–0.35) 0.135 
Dobutamine (µg/kg/min) 
Minimum  0 (0–1) 0 (0–2) 0.054 
Maximum 0 (0–3) 0.5 (0–5) 0.077 
Numerical data presented as median (minimum-maximum)., *Mann-Whitney test, p<0.05 considered significant, CE: continuous epidural; QLB: 
quadratus lumborum block 
 
DISCUSSION 
Continuous epidural analgesia is effective for managing 
postoperative pain associated with abdominal surgery; however, the 
hypotension side effects could place kidney transplant patients at 
risk of graft failure. Regional blocks, such as QLB, have demonstrated 
good analgesia during various abdominal procedures and could be 
used in kidney transplant surgery as a way to avoid the unfavorable 
hypotension of CE. 
No study has compared the analgesic effect of QLB directly with CE, 
except for a study by Rahendra et al. who investigated laparoscopic 
living donor nephrectomy and found no significant difference in pain 
intensity between QLB and CE, in agreement with the present study 
[13]. The similar pain intensity between the groups in this study may 
be related to a comparable spread of local anesthetic along the 
dermatomal or spinal nerve in both procedures. In CE, the local 
anesthetic acts directly on the nerve root, whereas the local anesthetic 
spreads transversally in QLB along the thoracolumbar fascial plane to 
block the nerve with similar dermatomal coverage [14]. 
Our study found dermatomal coverage of the QLB to extend from T8 
to L1, which was lower than the QLB coverage from T7 to T12 
reported by Murouichi and colleagues [15]. Kidney transplant 
laparotomy for recipients involves the abdominal area between the 
ribs and pelvis; therefore, the spread of local anesthetic covered the 
dermatome area of the incisions (T9–L1) and the analgesic effect 
was sufficient for surgical wound pain relief. Dam et al. 
demonstrated thoracic spread in cadaveric and magnetic resonance 
imaging studies in volunteers as a result of a more anterolateral 
penetration of the quadratus lumborum and anterior thoracolumbar 
fascia, which may be related to the cephalad distribution of local 
anesthetic. These findings support the fact that even though the QLB 
was performed at L4 level, the sensory blockade was found higher 
than L3 and L4 levels [16]. A higher block level does not contribute 
to a better analgesic effect. On the contrary, it could increase risk of 
hemodynamic instability due to a sympathetic block. The QLB can 
last for up to 24–48h due to shifting of the local anesthetic from 
intermuscular space to paravertebral space, which has plenty of 
adipose tissue. Low perfusion in the adipose tissue causes a low 
absorption of local anesthetic by the circulation, thereby extending 
the duration of analgesia [17]. This would also contribute to the low 
pain intensity observed in the present study. 
The morphine requirements were also assessed at various 
postoperative times. The cumulative 24h morphine requirement and 
the first PCA morphine attempt showed no significant differences 
between the two groups. A high anxiety level is correlated with a 
higher pain score and a higher PCA drug demand. Anxiety about pain 
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could lead to an anticipatory attitude, so that the patient would tend 
to press the PCA even though they have not experienced any pain. 
Morphine usage from PCA is highly dependent on the patient’s 
decision to press the PCA button; therefore, a good explanation and 
full patient understanding are critical for reducing unnecessary PCA 
usage for pain other than surgical pain [18]. 
In the present study, all patients were cooperative, oriented and tranquil. 
The Ramsay sedation scale assessment was conducted to evaluate the 
side effects of morphine usage. With a glomerular filtration rate of less 
than 50 ml/min/1.73m2, a patient could build up morphine-6-
glucuronidase and morphine-3-glucoronidase metabolites, that could 
lead to postoperative nausea vomiting, unexpected sedation effects, 
involuntary myoclonus, and respiratory depression [3, 19]. 
The vasoactive drug dosage seems to depend on the patient’s 
preoperative blood pressure, as patients with preoperative SBP>140 
mmHg had lower requirements for norepinephrine and dobutamine 
than patients with SBP<140 mmHg. The incidence of hypotension 
was about 4.6% in the QLB group, with local anesthetic spreading 
bilaterally to the paravertebral space. However, studies on this topic 
are still sparse [20, 21]. 
Epidural blocks using ropivacaine cause side effects correlated with 
dose and concentration. A study by Hong et al. showed that MAP and 
systemic vascular resistance (SVR) could decrease significantly in 
epidural with ropivacaine at doses of 0.75% but not at 0.375% and 
0.2% [22, 23]. Hemodynamic changes during an epidural could 
occur due to a sympathetic block, which could cause dilatation of 
arteries and veins; a decrease in SVR; inotropic and chronotropic 
function disturbance; and changes in cardiac output. Generally, an 
epidural block in the lower thorax or lumbar area does cause 
significant hemodynamic changes [24]. In our present study, both 
groups showed an adequate perfusion pressure, as indicated by 
adequate urine production. A study by Schnuelle et al. set a five-year 
graft survival cutoff value of 81.8% in patients with urine production 
of 630 ml within the first 24h compared to 54.6% in patients with 
first 24h urine production<630 ml [25]. 
Our study had several limitations. We did not include a control 
group using PCA morphine i. v. alone or a perioperative multimodal 
analgesia regimen for assessing the pain intensity and the 24h 
morphine requirements after surgery without regional anesthesia to 
determine the true analgesic value of QLB and CE. A further 
limitation arose in blinding since the QLB was performed as the two-
sided injections without the catheter, while CE was performed 
before general anesthesia induction and using an inserted catheter. 
However, these conditions were inevitable since these are the 
common approaches for using these blocks. The subjects were also 
patients with CKD who required renal replacement therapy; 
therefore, the risks and side effects of local anesthetic toxicity were a 
further concern that should be addressed in the future study to 
assess the safety profile of ropivacaine in CKD. Another limitation is 
that the block spread was assessed only one time at 1h after the 
surgery and was not re-assessed during the observation time; hence, 
this study did not evaluate block regression. 
In conclusion, postoperative analgesia of the QLB did not significantly 
differ from CE. Therefore, the QLB has potential as an alternative pain 
management approach following kidney transplantation laparotomy. 
The QLB had a similar 24h cumulative morphine requirement, 
postoperative pain intensity and time to first additional analgesic 
requirement when compared with CE following kidney transplantation 
laparotomy. The block spread of both approaches covered the desired 
target area and reached a 100% block at the T10–L1 level. 
CONCLUSION 
Postoperative analgesia of QLB did not differ significantly compared 
to CE. The QLB has potential as alternative pain management 
following kidney transplantation laparotomy. The QLB had similar 
24-hour cumulative morphine requirement, postoperative pain 
intensity, first additional analgesic required time in comparison with 
CE following kidney transplantation laparotomy. Postoperative 
block height covers the desired target area and reached 100% block 
at level T10–L1. 
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